CoChat

Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD

CHEN, Yan, CHEN, Ping, HANAOKA, Masayuki, DROMA, Yunden, KUBO, Keishi · 2008 · Respirology
Cited by 105

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and objective: Cyclooxygenase‐2 (COX‐2) and its product prostaglandin E 2 (PGE 2) have been demonstrated to play critical roles in inflammation in respiratory diseases. However, the role of COX‐2 in airway remodelling in COPD remains to be elucidated. Matrix metalloproteinase‐2 (MMP‐2) is associated with both inflammation and airway remodelling in COPD. The objective of this study was to measure the expression of COX‐2 and the concentrations of PGE 2 and MMP‐2, and to investigate the role of COX‐2 and PGE 2 in airflow limitation mediated by MMP‐2, in the pathogenesis of COPD. Methods: Forty‐three patients with stable COPD, twelve smoking control subjects and ten non‐smoking control subjects were enrolled. Induced sputum was obtained for measurement of the concentrations of PGE 2 and MMP‐2 by ELISA. COX‐2 protein expression was assessed by western blotting. Results: PGE 2 and MMP‐2 concentrations were significantly higher in both smoking control subjects and patients with COPD than in non‐smoking control subjects (P < 0.01). Moreover, the levels of PGE 2 and MMP‐2 were inversely correlated with FEV 1% predicted in COPD patients (PGE 2: r = −0.748, P < 0.01; MMP‐2: r = −0.801, P < 0.01). Levels of PGE 2 were also positively correlated with those of MMP‐2 in patients with COPD (r = 0.775, P < 0.01). Expression of COX‐2 protein was significantly higher in COPD patients than in non‐smoking control subjects. Conclusions: COX‐2 and its product PGE 2 are not only involved in airway inflammation, but may also contribute to the severity of airflow limitation mediated by MMP‐2 during progression of COPD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1843.2008.01365.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 105

Metadata

Authors
CHEN, Y., CHEN, P., HANAOKA, M., DROMA, Y., & KUBO, K.
Venue
Respirology
Publisher
Wiley
Published
2008-10-22
Volume
13
Issue
7
Pages
1014-1021
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W1972110742
Cited by
105
References
3
FWCI
7.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD. https://app.cochat.ai/papers/10.1111/j.1440-1843.2008.01365.x
The paper
CHEN, Y., CHEN, P., HANAOKA, M., DROMA, Y., & KUBO, K. (2008). Enhanced levels of prostaglandin E2 and matrix metalloproteinase‐2 correlate with the severity of airflow limitation in stable COPD. Respirology. https://doi.org/10.1111/j.1440-1843.2008.01365.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.